Bacteremia caused by Achromobacter and Alcaligenes species in 46 patients with cancer (1989-2003)

被引:137
作者
Aisenberg, G [1 ]
Rolston, KV [1 ]
Safdar, A [1 ]
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Infect Dis Infect Control & Employee Hlth, Unit 402, Houston, TX 77030 USA
关键词
D O I
10.1002/cncr.20604
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND. Achromobacter and Alcaligenes are emerging infectious gram-negative bacterial species that can affect immunosuppressed patients. The authors sought to determine the incidence and characteristics of bloodstream infections caused by these organisms in patients with underlying malignancies. METHODS. All consecutive episodes of hematogenous Achromobacter and Alcaligenes infections recorded from December 26, 1989, to July 27, 2003, were studied retrospectively. RESULTS. Fifty-two episodes occurred in 46 patients; 31 patients (67%) had hematologic malignancies, and 24 (52%) experienced neutropenia (< 500 cells/muL). Diabetes mellitus was present in 12 patients (26%), and high-dose corticosteroids were administered to 12 patients (26%). Seventeen of the 52 infectious episodes (33%) were nosocomial in origin, and 10 patients (22%) had sepsis syndrome. Achromobacter xylosoxidans was the most common cause of infection (47 of 52 episodes [94%]), followed by Ach. denitrificans (2 of 52 episodes [4%]) and Alcaligenes faecalis (1 of 52 episodes [2%]). Twenty-seven episodes (52%) were polymicrobial, and 3 patients (7%) had concurrent fungemia. Infected intravascular catheters were present in 13 of 52 cases (25%), pneumonia was encountered in 6 of 52 cases (12%), and urinary tract infections were present in 5 of 52 cases (10%). Most isolates exhibited in vitro susceptibility to carbapenems, antipseudomonal penicillins, and trimethoprim-sulfamethoxazole. Resistance to ciprofloxacin, levofloxacin, aminoglycosides, and monobactam was common. Seven deaths (15%) were attributable to Achromobacter species. Incidence rates for sepsis syndrome, multiorgan dysfunction (Acute Physiology and Chronic Health Evaluation [APACHE] II score > 16), and use of mechanical ventilation and pressor support were significantly higher in patients who died (P < 0.001). Logistic regression analysis revealed that sepsis syndrome and high APACHE II scores were predictors of increased 30-day mortality. CONCLUSIONS. Most infections caused by this group of nonfermentative gram-negative bacteria were attributable to Ach. xylosoxidans, and only one-third were acquired during hospitalization. The presence of sepsis syndrome has evolved as an independent predictor of poor outcome in patients with high-risk malignancies accompanied by Achromobacter bloodstream infections. (C) 2004 American Cancer Society.
引用
收藏
页码:2134 / 2140
页数:7
相关论文
共 25 条
  • [1] [Anonymous], [No title captured]
  • [2] Kerstersia gyiorum gen. nov., sp nov., a novel Alcaligenes faecalis-like organism isolated from human clinical samples, and reclassification of Alcaligenes denitrificans Ruger and Tan 1983 as Achromobacter denitrificans comb nov.
    Coenye, T
    Vancanneyt, M
    Cnockaert, MC
    Falsen, E
    Swings, J
    Vandamme, P
    [J]. INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY, 2003, 53 : 1825 - 1831
  • [3] Achromobacter xylosoxidans bacteremia: Report of four cases and review of the literature
    Duggan, JM
    Goldstein, SJ
    Chenoweth, CE
    Kauffman, CA
    Bradley, SF
    [J]. CLINICAL INFECTIOUS DISEASES, 1996, 23 (03) : 569 - 576
  • [4] Dupon M, 1993, Intensive Care Med, V19, P480
  • [5] EDWARDS A, 2000, CRIT CARE MED, V28, P232
  • [6] ACHROMOBACTER SEPTICEMIA - FATALITIES IN PREMATURES .1. CLINICAL AND EPIDEMIOLOGICAL STUDY
    FOLEY, JF
    ENGLEHARD, WE
    GRAVELLE, CR
    CHIN, TDY
    [J]. AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1961, 101 (03): : 279 - +
  • [7] Achromobacter xylosoxidans bacteremia:: A 10-year analysis of 54 cases
    Gómez-Cerezo, J
    Suárez, I
    Ríos, JJ
    Peña, P
    de Miguel, MJG
    de José, M
    Monteagudo, O
    Linares, P
    Barbado-Cano, A
    Vázquez, JJ
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2003, 22 (06) : 360 - 363
  • [8] Hernández JA, 1998, HAEMATOLOGICA, V83, P284
  • [9] STRAINS OF ACHROMOBACTER-XYLOSOXIDANS FROM CLINICAL MATERIAL
    HOLMES, B
    SNELL, JJS
    LAPAGE, SP
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 1977, 30 (07) : 595 - 601
  • [10] CLINICAL AND LABORATORY CHARACTERISTICS OF ACHROMOBACTER-XYLOSOXIDANS INFECTION
    IGRASIEGMAN, Y
    CHMEL, H
    COBBS, C
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1980, 11 (02) : 141 - 145